Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Complementary and Alternative Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Sex differences in acupuncture effectiveness in animal models of Parkinson's disease: a systematic review

BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201616:430

https://doi.org/10.1186/s12906-016-1405-5

Received: 8 January 2016

Accepted: 19 October 2016

Published: 3 November 2016

Abstract

Background

Many animal experimental studies have been performed to investigate the efficacy of acupuncture in Parkinson’s disease (PD). Sex differences are a major issue in all diseases including PD. However, to our knowledge, there have been no reviews investigating sex differences on the effectiveness of acupuncture treatment for animal PD models. The current study aimed to summarize and analyze past studies in order to evaluate these possible differences.

Method

Each of 7 databases (MEDLINE, EMBASE, the Cochrane Library, 3 Korean medical databases, and the China National Knowledge Infrastructure) was searched from its inception through March 2015 without language restrictions.

Results

We included studies of the use of acupuncture treatment in animal models of PD. A total of 810 potentially relevant articles were identified, 57 of which met our inclusion criteria. C57/BL6 mice were used most frequently (42 %) in animal PD models. Most of the studies were carried out using only male animals (67 %); only 1 study (2 %) was performed using solely females. The further 31 % of the studies used a male/female mix or did not specify the sex.

Conclusions

The results of our review suggest that acupuncture is an effective treatment for animal PD models, but there is insufficient evidence to determine whether sex differences exist. Future studies of acupuncture treatment for PD should use female animal models because they reflect the physiological characteristics of both males and females to fully evaluate the effect and the safety of the treatment for each sex.

Keywords

Electro-acupunctureManual acupunctureBee-venom acupunctureC57/BL6Acupuncture point

Background

Parkinson’s disease (PD) is a progressive neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra [1]. PD usually occurs in individuals over 50 years of age, and its incidence and prevalence increases among individuals approximately 60 years of age and older. PD has become more common due to the rapid aging of human populations around the world [2]. Epidemiological studies have reported that the incidence of PD is 1.5–2 times higher in men than in women, and the onset of symptoms may occur later in women due to the neuroprotective effects of estrogen [3]. For the disease manifestations of PD, women have higher Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores, but present with dyskinesia, tremor, and PD-related complications more often than men [4].

Because the FDA reported that eight out of ten new drugs that had been sold on the market were discontinued because they resulted in far more detrimental side effects in women, the sex perspective began to be discussed in many other fields as well [5]. Adverse drug reactions can be caused by the physiological difference between men and women, and women can be more vulnerable to a particular drug [6]. Because sex is often not considered an important variable in animal research with the exception of research related to features of a particular sex, such as reproduction and endocrine secretion, the overwhelming majority of experimental research uses only males and many studies do not even disclose the sex of the experimental animals. Basic research studies using cells in culture also often fail to present the sex of the organism from which the cell strain originated, but the results of such basic research has been applied generally to humans. Because medical research studies are performed primarily by male researchers [79], the research subjects are also mostly males [1012], and there has been a tendency to be careless of females [13], which can aggravate treatment problems related to the physiological differences between men and women. The National Institutes of Health (NIH) requires applicants to report their cell and animal inclusion plans as part of the preclinical experimental design [14]. Therefore, studies are being performed to determine what sex differences need to be accounted for in preclinical and clinical stages, and the importance of the applying these principles is being highlighted [15].

PD treatment options include pharmacological treatment, non-pharmacological treatment, surgical therapy, and dopaminergic cell transplantation [15]. Acupuncture has long been employed for numerous disorders, and it has been traditionally used to relieve PD-related symptoms and to delay the clinical progression of PD symptoms [16]. We have reported that acupuncture exerts increased neuroprotective effects in regions including the substantia nigra, caudate, thalamus, and putamen in animal models of PD [1720]. Acupuncture was also found to inhibit microglial activation, inflammation, and iron-related oxidative damage in PD [21].

Sex differences have emerged recently as an important issue, but sufficient efficacy tests for sex differences in acupuncture, as in preclinical studies for drug development, have not yet been performed. It is necessary to clarify efficacy differences according to sex in order to more effectively utilize acupuncture in clinical practice. Therefore, we carried out the present study to identify whether adequate research has been conducted so far to determine the sex differences in the efficacy of acupuncture. Specifically, we analyzed past studies of acupuncture treatment conducted in animal PD models, and determined whether the body of data was sufficient to determine the effects of sex differences on the effectiveness of acupuncture treatment. This review provides the basis for establishing whether future animal model studies are necessary to determine possible sex-related differences in the efficacy of acupuncture for PD.

Methods

Search methods for the identification of studies

The search was performed without restrictions on language or year of publication. We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials from the inception of each database through March 2015. For Korean publications, we searched three Korean medical databases (Research Information Service System, National Discovery for Science Leaders, and OASIS). For Chinese articles, we searched the China National Knowledge Infrastructure. The keywords used for the search were the following: “Parkinson’s disease” OR “Parkinson” AND “acupuncture” OR “acupoints” OR “electroacupuncture” OR “electro-acupuncture” OR “auriculotherapy” OR “auriculoacupuncture” OR “bee venom acupuncture” in each database language. The search strategy was adjusted for each database.

Inclusion/exclusion criteria

We included studies of the use of acupuncture treatment in animal PD models. Trials were excluded if the study designs did not evaluate the effectiveness of acupuncture in animal PD models, or if they reported insufficient data. No search restrictions on language or publication forms were imposed. During the first stage of selection/exclusion, titles and abstracts were analyzed, and literature that had no relevance to our study was excluded. The second stage of selection/exclusion involved analyzing the full text of particular studies, because it was impossible to determine the relevance of the studies based solely on the abstracts.

Data extraction

Two reviewers (LSH and KJY) independently reviewed the data extracted from each article using a standardized data extraction form and reached consensus on all items. The extracted data included the type of animal PD models, the sex of the animal PD models, the methods used to induce PD, the types of acupuncture, the acupuncture points, and the effectiveness of the treatment.

Results

Study description

We identified 810 publications, 57 of which met the eligibility criteria (Fig. 1). The 57 articles were published from 1996 to 2014. The characteristics of the studies are summarized in Table 1 [712, 18, 19, 2169].
Fig. 1

Flowchart of the study selection process

Table 1

Summary of acupuncture for animal PD models

First author (year)

Type of animal PD models

Sex of animal PD models

Drugs used to induce PD

Types of acupuncture

Types of acupuncture points

Evaluation of the treatment effectiveness

Bai (2014a) [22]

Undefined

Undefined

6-OHDA

EA

GV20, EX-HN5

DA

Bai (2014b) [8]

Undefined

Male

6-OHDA

EA

GV20, EX-HN5

Caspase-3

Feng (2014) [10]

C57BL/6

Male

MPTP

MA

Undefined

Pole-climbing test, BDNF, TH, DA

Yeo (2013) [19]

C57BL/6

Male

MPTP

MA

GB34, LR3

TH, gene expression

Alvarez-Fischer (2013) [7]

C57BL/6

Male

MPTP

BV

Undefined

DA, DOPAC, IL-1β, IL-6, TNF-α, HVA, TH, rotational test

Ding (2013) [11]

SD

Male

6-OHDA

EA

LI4, LR3

nNOS, GFAP

Wang (2013a) [9]

SD

Male

Rotenone

EA

GV16, LR3

TH, COX-2

Wang (2013b) [23]

SD

Male

Rotenone

EA

GV16, LR3

TH, p-p38 MARK, COX-2

Wang (2013c) [12]

SD

Male

Rotenone

EA

GV16, LR3

TH, SOD, GSH, CAT, MDA

Wang (2013d) [24]

SD

Male

Rotenone

EA

GV16, LR3

UCH-L1, UBE1, Parkin, TH, α-synuclein

Ding (2012) [25]

SD

Male

6-OHDA

EA

LI4, LR3

TH, GFAP, PCNA

Huang (2012) [26]

ICR

Male

MPTP

EA

GB34

Lamp 1, α-synuclein

Lu (2012) [27]

C57BL/6

Male

MPTP

EA

GV20, GV16, GB34

Locomotor counts, swimming test, pole-climbing test

Guo (2012) [28]

SD

Male

6-OHDA

EA

GV20, GV16, GB34

GSH, SOD, MDA, GSH-Px

Yang (2011) [29]

C57BL/6

Male

MPTP

EA

PC7

Pole-climbing test, TH, DA, DOPAC, HVA

Choi (2011) [18]

C57/BL6

Male

MPTP

MA

GB34, LR3

TH, DAT, gene expression

Kim (2011) [30]

C57BL/6

Male

MPTP

BV

ST36

MAC-1, iNOS, TH

Du (2011) [31]

SD

Male

6-OHDA

EA

GV20, GV14

GABA, rotational test

Wang (2011) [32]

C57BL/6

Male

MPTP

EA

ST36, SP6

TH, DA, DOPAC, HVA, SOD, GSH, GSH-Px

Doo (2010) [33]

C57BL/6

Male

MPTP

BV

GB34

TH

Hong (2010) [34]

C57BL/6

Male

MPTP

MA

GB34

Gene expression

Jun (2010) [35]

C57BL/6

Male

MPTP

BV

BL23

TH, caspase-3, iNOS

Kim (2010) [36]

C57BL/6

Male

MPTP

EA

GB34, GB39

DA

Park (2010) [37]

C57BL/6

Male

MPTP

BV

GB39, LI11, BL23

TH, MAC-1, HSP70

Sun (2010) [38]

C57BL/6

Male

MPTP

MA

GV20, GV14

Pole-climbing test, TH, DA, DOPAC

Wang (2010a) [39]

Wistar

Undefined

6-OHDA

EA

GV16, LR3

TH, DA

Wang (2010b) [40]

Wistar

Undefined

6-OHDA

EA

GV16, LR3,CV4, ST36

GDNF

Wang (2010c) [41]

C57/BL6

Male

MPTP

MA

GV20, GV14

Pole-climbing test, TH, DA, NA, DOPAC, 5HIAA, 5HT

Yu (2010) [42]

Wistar

Male

6-OHDA

MA

GB34, LR3, ST36, SP10

Rotational test, SOD, GSH-Px, CAT, GSH, MDA

Huang (2010) [43]

Wistar

Male

6-OHDA

EA

LI4, LR3

Rotational test, BDNF, TrKB

Choi (2009) [21]

C57/BL6

Male

MPTP

MA

LR3, GB34

TH, DAT

Kim (2009) [44]

C57BL/6

Male

MPTP

BV

BL23

TH, MAC-1, HSP70

Wang (2009a) [45]

Wistar

Male, Female

6-OHDA

EA

GV20, EX-NH5

TH, BDNF

Wang (2009b) [46]

Wistar

Male, Female

6-OHDA

EA

GV20, EX-NH5

TH, DAT

Kim (2008) [47]

C57BL/6

Male

MPTP

MA

GB34

TH

Guan (2008) [48]

C57BL/6

Male

MPTP

EA

GV20

Fn

Wang (2008) [49]

Wistar

Male, Female

6-OHDA

EA

GV20, EX-NH5

TH

Jeon (2008) [50]

C57BL/6

Male

MPTP

EA

GB34, SI3, BL62, ST36

Pole-climbing test, TH, DA, BDNF

Xie (2007) [51]

Wistar

Undefined

6-OHDA

MA

GV20

Rotational test, MDA, NO, SOD

Kang (2007) [52]

C57BL/6

Male

MPTP

MA

GB34, LR3

TH, COX-2, iNOS, DA, DOPAC, HVA

Huang (2007) [53]

SD

Male

6-OHDA

MA

GB34, LR3

TH

Luo (2007) [54]

Wistar

Male, Female

6-OHDA

EA

GV20, EX-NH5

NOS

Wang (2007) [55]

SD

Male, Female

6-OHDA

MA

GV20, GV16, GB34

Rotational test, DA

Jin (2006a) [56]

Wistar

Male, Female

6-OHDA

EA

Undefined

GSH, GSH-Px,SOD, MDA, NOS

Jin (2006b) [57]

Wistar

Male, Female

6-OHDA

EA

Undefined

DA, HVA, DOPAC

Ma (2006) [58]

Wistar

Male, Female

6-OHDA

EA

GV16, LR3

Rotational test, DA

Tang (2006) [59]

C57BL/6

Male

MPTP

EA

LI4, LR3

BDNF

Wang (2006) [60]

SD

Male, Female

6-OHDA

EA

GV16, LR6

Glutamic acid

Kim (2006) [61]

C57BL/6

Male

MPTP

MA

LR8, LR4, LR2

TH

Kim (2005) [62]

SD

Undefined

6-OHDA

MA

ST36

Rotational test, TH

Ma (2005) [63]

Wistar

Male, Female

6-OHDA

EA

GV16, LR3

Rotational test, SOD, GSH, GSH-Px

Wang (2005) [64]

Wistar

Undefined

6-OHDA

MA

GV16, LR3, CV4, ST36

TH

Park (2003) [65]

SD

Male

6-OHDA

MA

GB34, LR3, LI4, LI11

Rotational test, TH, TrkB

Liang (2002) [66]

Wistar

Female

MFB transection

EA

GV14, GV21

TH, BDNF

Lin (2000) [67]

SD

Male, Female

6-OHDA

EA

LR3, SP6, ST36, GB34

DA, HVA, DOPAC

He (1998) [68]

SD

Male, Female

6-OHDA

EA

GV20, GV14

DA, NA, 5HT

Zhu (1996) [69]

C57BL/6

Male

MPTP

MA

GV20

DA, DOPAC

Abbreviations: BDNF Brain-derived neurotrophic factor, BV Bee-venom acupuncture, CAT Catalase, Caspase-3: caspase protein, COX-2 Cyclooxygenase-2, DA Dopamine, DAT Dopamine active transporter, DOPAC Dihydroxyphenyl acetic acid, EA Electro-acupuncture, Fn Ferritin, GABA gamma-aminobutyric acid, GDNF Glial cell-derived neurotrophic factor, GFAP Glial fibrillary acidic protein, GSH Glutathione, GSHpx Glutathione peroxidase, HSP70 70 kilo Dalton heat shock proteins, HVA Homovanillic acid, IL-1β Interleukin-1 beta, IL-6 Interleukin-6, iNOS Inducible nitric oxide synthase, Lamp 1 Lysosomal-associated membrane protein 1, MA Manual acupuncture, MAC-1 Macrophage-1 antigen, MDA Malondialdehyde, NO Nitric oxide, nNos Neuronal nitric oxide synthase, MFB Medial forebrain bundle, MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, p-p38 MARK Phospho-p38 MAPK, PCNA Proliferating cell nuclear antigen, SD Sprague–Dawley, SOD Superoxide dismutase, TH Tyrosine hydroxylase, TNF-α Tumor necrosis factor alpha, TrkB Tropomyosin receptor kinase B, UBE1 Ubiquitin-like Modifier Activating Enzyme 1, UCH-L1 Ubiquitin C-terminal hydrolase, 5HIAA 5-Hydroxyindoleacetic acid, 5HT 5-hydroxytryptamine, 6-OHDA 6-hydroxydopamine

Animals of PD models

The animals of PD models included mice (C57/BL6 and ICR) and rats (Sprague–Dawley, and Wistar) (Fig. 2). The most frequently used animal PD model was C57/BL6, which was used in 24 articles, followed by SD and Wistar, each of which were used in 15 articles, and ICR and undefined animals, which were used in one article each. All of the studies using C57/BL6 animals used only males. Of the studies using SD animals, ten used males only, four used a male/female mix, and one used animals with undefined sex. Of the studies using Wistar animals, nine used a male/female mix, two used males only, three used animals with undefined sex, and one study used females only.
Fig. 2

Sex differences according to the types of animal used as PD model

Methods used to induce PD

The drugs 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and rotenone, as well as medial forebrain bundle (MFB) transection, were used to induce PD in the animal models (Fig. 3). 6-OHDA was used in 47 % (27) of the studies, MPTP was used in 44 % (25) of the studies, and rotenone was used in 7 % (4) of the studies. MFB transection was used in 2 % (1) of the studies. Of the studies using 6-OHDA, 13 used a male/female mix, nine used only males, and five used animals with undefined sex. All of the studies using MPTP or Rotenone used only male animals. The study using MFB transection used only females. Therefore, three out of the four PD induction models studied were only used in animals of a single sex. Only the results of 6-OHDA induced animal PD models could potentially be compared between the sexes.
Fig. 3

Sex differences according to the method used to induce PD

Types of acupuncture

Electro-acupuncture (EA) was used in 54 % (38) of the studies, manual acupuncture (MA) was used in 30 % (18) of the studies, and bee-venom (BV) acupuncture was used in 11 % (6) of the studies. Of the studies using EA, 18 used only males, 11 used a male/female mix, three used animals of undefined sex, and one used only females. Of the studies using MA, 14 used only males, two used a male/female mix, and two used animals with undefined sex. All of the studies using BV acupuncture used only males (Fig. 4).
Fig. 4

Sex differences according to the type of acupuncture performed

Acupuncture points

Regardless of the type of acupuncture, the acupuncture points used consisted mainly of LR3, GB34, GV20, GV16, and ST36 (Additional file 1). LR3 was used in 35 % (20) of the studies, and GV34 and GV20 were each used in 26 % (16) of the studies. Of the studies using LR3, 14 used only males, three used a male/female mix, and three used animals with undefined sex. Of the studies using GB34, 14 used only males, and two used a male/female mix. Of the studies using GV20, eight used only males, seven used a male/female mix, and one used animals with undefined sex. Of the studies using GV16, seven used only males, three used a male/female mix, and three used animals with undefined sex. Of the studies using ST36, four used only males, two used animals with undefined sex, and one used a male/female mix.

Behavioral test

Behavioral analyses were carried out using the rotational behavior test, the pole-climbing test, the swimming test, and locomotor counts (Additional file 2). The rotational behavior test was used in 56 % (10) of the studies, the pole-climbing test was used in 22 % (6) of the studies, and the swimming test, and locomotor counts were each used in 6 % (1) of the studies. The rotational behavior test was mainly used in conjunction with 6-OHDA (8 studies), the pole-climbing test was used in conjunction with MPTP (6 studies), and the swimming test and locomotor counts were each used in conjunction with MPTP (Additional file 3). The rotational behavior test was used in five studies with only males, four studies with a male/female mix, and one study with animals with undefined sex. The studies using the pole-climbing test, the swimming test, and locomotor counts were each conducted with males only. Of all studies including behavioral analyses, 72 % (13) of the studies used only male animals, 22 % (4) used a male/female mix, and 6 % (1) used animals with undefined sex. In these studies, PD was induced using MPTP in 53 % (9) of the studies and 6-OHDA in 47 % (8).

Evaluation of treatment effectiveness

The effectiveness of the treatment on PD was evaluated by levels of tyrosine hydroxylase (TH), dopamine (DA), dihydroxyphenyl acetic acid (DOPAC), homovanillic acid (HVA), superoxide dismutase (SOD), glutathione (GSH), and brain-derived neurotrophic factor (BDNF) (Additional file 4). TH was the most frequently used method to determine the effectiveness of the treatment on PD (56 % [32] of the studies). Of the studies using TH, 26 used only males, two used a male/female mix, three used animals with undefined sex, and one used only females. Of the studies using DA, ten used only males, five used a male/female mix, and two used animals with undefined sex. Of the studies using DOPAC, seven used only males, and two used a male/female mix. Of the studies using HVA and GSH, respectively, four of each used only males, and two of each used a male/female mix. Of the studies using SOD, four used only males, and two used a male/female mix. Of the studies using BDNF, four used only males, one used a male/female mix, and one used only females.

Discussion

We analyzed sex differences among previous studies that used animal PD models of acupuncture treatment. A total of 810 potentially relevant articles were identified, 57 of which met our inclusion criteria. C57/BL6 mice were the most frequently used (42 %) animal PD models. Most of the studies evaluating the effectiveness of acupuncture treatment for PD were performed using only male animals (67 %); only one study (2 %) was performed using female animals.

Many studies have inadvertently excluded females from animal studies of acupuncture treatment for PD. Kang et al. suggested that acupuncture could be used as a neuroprotective intervention for inhibiting microglial activation and inflammatory events in the MPTP-induced male PD model [52]. Yu et al. showed that acupuncture treatment displays antioxidative and/or neuroprotective properties in the 6-OHDA lesioned male rat PD models [3]. Although a few studies were performed using a male/female mix, they could not combine and compare the results from male versus female animals. Only one report used female animals, in which was a study in which different frequencies of chronic EA stimulation were tested in a partially-lesioned female rat model of PD induced by transection of the MFB. This study suggested that long-term high frequency EA is effective in halting the degeneration of dopaminergic neurons in the substantia nigra (SN). Because the studies of male PD models generated using MFB transection are nonexistent, we could not compare the sex differences in this model. Taken together, there is currently insufficient evidence from past studies to determine whether there are sex differences in the effectiveness of acupuncture for animal PD models. In the future, studies should be performed using a male/female mix to minimize performance bias, and ideally should include a comparison of the sex differences.

Animal studies have often focused primarily on males. For the most part, examination of the differences between males and females has been disregarded in biomedical research, leaving gaps in our knowledge [42]. Recently, new drugs have been developed without considering the physiological characteristics of females or sex differences. Women have therefore been frequently exposed to dangerous side effects because the experimental studies and clinical trials had mainly used male subjects [70]. The lack of female participation in drug-development studies affects males as well as females; when side effects not seen in males during the drug safety checks appear in females, the approval of the drugs is delayed, and male patients waiting for the drugs consequently suffer. The NIH requires applicants to report their cell and animal inclusion plans as part of the preclinical experimental design. Despite this NIH policy, numerous scientific publications continue to neglect sex-based considerations and analyses in preclinical and clinical research. A stronger commitment to reporting sex-specific results will strengthen the evidence base [13]. Fortunately, sex differences are increasingly recognized as factors that influence the incidence and disease manifestations of all diseases, including neurodegenerative disorders.

Some gender differences have been documented for PD [3, 4]. Paven et al. suggested gender differences in the epidemiology, clinical features, treatment outcomes (medical and surgical/deep brain stimulation), and social impact among all available PD studies [4]. Wooten et al. performed a meta-analysis of the differences in the incidence of PD between men and women [3]. Smith et al. summarized evidence that estrogen and selective estrogen receptor modulators are neuroprotective in PD, and reviewed sex differences in basal ganglia function and dopaminergic pathways [71, 72]. Consistent with these past studies, if acupuncture research involved both males and females, additional studies of acupuncture for PD would provide a more robust conclusion about sex differences in this treatment.

Review limitations and future areas of research

A number of gaps in the reviewed literature were identified in relation to study quality and findings. Study quality could be improved by using female animal models because they reflect the physiological characteristics of both males and females to fully evaluate the effectiveness and safety of the treatment for each sex, which is largely missing in the literature so far.

Conclusions

The results of our review suggest that acupuncture is an effective treatment for animal PD models, but there is insufficient evidence to determine whether sex differences exist in response to this treatment. Future studies should examine the effects of acupuncture in animal PD models of both sexes, to reflect the physiological characteristics of females as well as males, and to fully evaluate the effect and safety of this treatment.

Abbreviations

BDNF: 

Brain-derived neurotrophic factor

BV: 

Bee-venom acupuncture

DA: 

Dopamine

DOPAC: 

Dihydroxyphenyl acetic acid

EA: 

Electro-acupuncture

GSH: 

Glutathione

HVA: 

Homovanillic acid

MA: 

Manual acupuncture

MFB: 

Medial forebrain bundle

MPTP: 

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

SD: 

Sprague-Dawley

SOD: 

Superoxide dismutase

TH: 

Tyrosine hydroxylase

6-OHDA: 

6-hydroxydopamine

Declarations

Acknowledgements

We would like to thank Jong-Yeop Kim for his assistance with the collection of data used for this study.

Funding

This work was supported by the Mid-Career Research Program through an NRF grant funded by the Korean government (No. 2014R1A2A1A11052795).

Availability of data and materials

The data sets supporting the conclusions of this article are included within the article.

Authors’ contributions

SHL and SL created the study background and designed the study; SHL performed data acquisition and analysis, and drafted the article; SL conducted the literature review; MvdN, PB and SL revised the article. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

This information is not relevant.

Ethics approval and consent to participate

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Applied Korean Medicine, Graduate School, Kyung Hee University
(2)
Research Group of Pain and Neuroscience, WHO Collaborating Center for Traditional Medicine, East–west Medical Research Institute, Kyung Hee University
(3)
Donders Institute for Brain, Cognition and Behaviour, Radboud University
(4)
Department of Meridian & Acupoint, College of Korean Medicine, Kyung Hee University

References

  1. Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov Disord. 2008;23 Suppl 3:548–59.View ArticleGoogle Scholar
  2. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet. 2004;363(9423):1783–93.View ArticlePubMedGoogle Scholar
  3. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry. 2004;75(4):637–9.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Pavon JM, Whitson HE, Okun MS. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas. 2010;65(4):352–8.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Wald C, Wu C. Biomedical research. Of mice and women: the bias in animal models. Science. 2010;327(5973):1571–2.View ArticlePubMedGoogle Scholar
  6. Haack S, Seeringer A, Thürmann PA, Becker T, Kirchheiner J. Sex-specific differences in side effects of psychotropic drugs: genes or gender? Pharmacogenomics. 2009;10(9):1511–26.View ArticlePubMedGoogle Scholar
  7. Alvarez-Fischer DC, Noelker F, Vulinović A, Grünewald C, et al. Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. Plos One. 2013;8(4):e61700.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Yan B, Zhigang L, Hu B, et al. Effects of electro-acupuncture on Baihui and Taiyang points on caspase- 3 expression and apoptosis of substantia nigra dopaminergic neurons of rats with Parkinson disease. Chinese J Tradit Med Sci &Tech. 2014;21(5):534–6.Google Scholar
  9. Wang YC, Xu YH, Ma J, et al. Effects of electric acupuncture on the oxidative stress in the rat of Parkinson’s disease abductioned by rotenone. Hubei Univ of TCM. 2013;28(8):2417–9.Google Scholar
  10. Feng J, Sun HM, Wang YY, et al. Influences of needling chorea-tremble controlled zone on expressions of dopaminergic neurons and BDNF in mice with Parkinson’s disease. J Beijing Univ TCM. 2014;37(1):53–7.Google Scholar
  11. Ding YX, Zhao J, Hou LQ. Effects of electroacupuncture on the expressions of neuroal nitric oxide synthase and astrocyte in dentate gyrus of rats with Parkinson's disease. Chin acupunct& mox. 2013;33(6):533–7.Google Scholar
  12. Wang SJ, Fang JQ, Ma J. Effect of electroacupuncture stimulation of ``Fengfu'' (GV 16) and ``Taichong'' (LR 3) on expression of COX-2 and tyrosine hydroxylase in substantia nigra in rats with Parkinson's disease. Acupuncture Research. 2013;38(3):198–201.PubMedGoogle Scholar
  13. Anita H. Gender bias in research: how does it affect evidence based medicine? J R Soc Med. 2007;100(1):2–3.View ArticleGoogle Scholar
  14. Clayton JA, Collins FS. NIH to balance sex in cell and animal studies. Nature. 2014;509(7500):282–3.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Raz L, Miller VM. Considerations of sex and gender differences in preclinical and clinical trials. Handb Exp Pharmacol. 2012;214:127–47.View ArticleGoogle Scholar
  16. Singh N, Pillay V, Choonara YE. Advances in the treatment of Parkinson’s disease. Prog Neurobiol. 2007;81(1):29–44.View ArticlePubMedGoogle Scholar
  17. Walton-Hadlock J. Primary Parkinson's disease: the use of Tuina and acupuncture in accord with an evolving hypothesis of its cause from the perspective of Chinese traditional medicine--part 2. Am J Acupunct. 1999;27(1–2):31–49.PubMedGoogle Scholar
  18. Choi YG, Yeo S, Hong YM, Lim S. Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Cell Mol Neurobiol. 2011;31(3):377–91.View ArticlePubMedGoogle Scholar
  19. Yeo S, Choi YG, Hong YM, Lim S. Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Gene. 2013;515(2):329–38.View ArticlePubMedGoogle Scholar
  20. Yeo S, Lim S, Choe IH, Choi YG, Chung KC, Jahng GH, Kim SH. Acupuncture stimulation on GB34 activates neural responses associated with Parkinson's disease. CNS Neurosci Ther. 2012;18(9):781–90.View ArticlePubMedGoogle Scholar
  21. Choi YG, Park JH, Lim S. Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced Parkinsonism model. Neurosci Lett. 2009;450(2):92–6.View ArticlePubMedGoogle Scholar
  22. Bai Y, LI ZG, Wang S, et al. Study on protective effect of different electro- acupuncture on Baihui and Taiyang points on dopaminergic neurons of rats with Parkinson Disease. Chin Med Sci Tech. 2014a;21(5):536–8.Google Scholar
  23. Wang SJ, Fang JQ, Ma J, et al. Influence of electroacupuncture on p38-mitogen activated protein kinase in substantia nigra cells of rats with Parkinson disease model. Chin Acupunct Mox. 2013b;33(4):329–33.Google Scholar
  24. Wang YC, He F, Ma J, et al. impacts of electroacupuncture on ubiquitin-proteasome system in rats with Parkinson’s disease. Hubei Univ TCM. 2013d;33(8):725–9.Google Scholar
  25. Ding YX, Hou LQ, Xiong KR. Effect of electroacupuncture on expression of proliferating cell nuclear antigen and glial fibrillary acidic protein in subventricular zone of Parkinson's disease rats. Acupunct Res. 2012;37(4):286–90.Google Scholar
  26. Huang Q, Sun Y, Wang L, Zhang Y, et al. Acupuncture improve motor function in a mouse model of Parkinson's disease. Nucl Tech. 2012;35(11):877–80.Google Scholar
  27. Lu ZY, Zhao H, Wang T. Effects of Acupuncture on Behavior and Striatal Apoptosis in Mice with Parkinson Disease. Acupunct Res. 2012;37(3):186–90.Google Scholar
  28. Guo CX, Zhang L, Shao SJ, Hao L, et al. Oxidative stress effects of electro-acupuncture for "Baihui ", "Fengfu", "Yanglingquan " on PD model rat. Yunnan Univ TCM. 2012;35(5):26–9.Google Scholar
  29. Yang JL, Chen JS, Yang YF, et al. Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice. Brain Behav Immun. 2011;25(7):1452–9.View ArticlePubMedGoogle Scholar
  30. Kim JI, Yang EJ, Lee MS, et al. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease. Int J Neurosci. 2011;121:209–17.View ArticlePubMedGoogle Scholar
  31. Du J, Sun ZL, Jia J, Wang X, et al. High-frequency electro-acupuncture stimulation modulates intracerebral γ-aminobutyric acid content in rat model of Parkinson’s disease. Acta Physiol Sinica. 2011;63(4):305–10.PubMedGoogle Scholar
  32. Wang H, Pan Y, Xue B, et al. The Antioxidative Effect of Electro-Acupuncture in a Mouse Model of Parkinson’s Disease. PLoS ONE. 2011;6(5):e19790.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Doo AR, Kim ST, Kim SN, et al. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Neurolog Res. 2010;32 Suppl 1:88–91.View ArticleGoogle Scholar
  34. Hong MS, Park HK, Yang JS, et al. Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2, 3,6- tetrahydropyridine-induced Parkinson's disease model. Neurol Res. 2010;32 Suppl 1:S74–8.View ArticleGoogle Scholar
  35. Jun HJ, Kim YS. Dose-dependent Effects of Bee Venom Acupuncture on MPTP-induced Mouse Model of Parkinson's Disease. J Korean Acupunct Mox Med Sci. 2010;27(5):59–68.Google Scholar
  36. Kim ST, Moon W, Chae Y, et al. The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum. J Physiol Sci. 2010;60:27–34.View ArticlePubMedGoogle Scholar
  37. Park W, Kim JK, Kim JI, et al. Neuroprotective and Anti-inflammatory Effects of Bee Venom Acupuncture on MPTP-induced Mouse. J Korean Acupunct Mox Med Sci. 2010;27(3):105–16.Google Scholar
  38. Sun H, Wu H, Xu H, et al. Protective effect of acupuncture in acupoints of Governor Vessel on dopaminergic neurons protection and influence on ultrastructure in mice with Parkinson’s disease. Beijing Univ TCM. 2010;33(4):257–62.Google Scholar
  39. Wang YC, Cheng YH, Ma J, et al. Effect of electroacupuncture on morphological changes and apoptosis of substantia nigra cells in Parkinson's disease rats. Acupunct Res. 2010a;35(6):415–21.Google Scholar
  40. Wang YC, Cheng YH, Ma J, et al. Effects of electroacupuncture on the expression of GDNF and Ret in Parkinson’s disease model rats. Hubei Univ TCM. 2010b;30(9):739–43.Google Scholar
  41. Wang YY, Sun HM, He X, et al. The protection effect of acupuncture of baihui and dazhui points on the dopaminergic neurons in PD mice. Prog Anatomic Sci. 2010c;16(1):16–20.Google Scholar
  42. Yu YP, Ju WP, Li ZG, Wang DZ, Wang YC, Xie AM. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res. 2010;1336:58–65.View ArticlePubMedGoogle Scholar
  43. Huang PP, Ma J, Wang Y, et al. Effect of electroacupuncture on the expression of BDNF and TrKB in mesencephic substantia nigra of the Parkinson 's disease model rats. J Hubei Univ Chin Med. 2010;12(2):3–5.Google Scholar
  44. Kim CY, Lee JD, Lee SH. Anti-inflammatory Effect of Bee Venom Acupuncture at Sinsu (BL23) in a MPTP Mouse Model of Parkinson Disease. J Korean Acupunct Mox Med Sci. 2009;26(4):49–58.Google Scholar
  45. Wang S, Jiang H, Qu L. Study on the mechanism of electroacupuncture scalp point penetration therapy in action on apoptosis in the Parkinson's disease rat model. Chin Acupunct Mox. 2009a;29(4):309–13.Google Scholar
  46. Wang S, Qi XJ, Han D. Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats. Chin Acupunct Mox. 2009b;29(5):391–4.Google Scholar
  47. Kim YJ, Kim BS, Park HJ. Acupuncture at GB34 modulates laminin expression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. J Acupunct Acupoint. 2008;25(1):155–64.Google Scholar
  48. Guan T, Sun H, Zhang L, et al. The effects of electroacupuncture for iron protein and stained cells in the substantia nigra in Parkinson 's disease model mice. Chin J Histochem Cytochem. 2008;17(5):427–31.Google Scholar
  49. Wang S, Qi XJ, Han D. Impacts of penetration therapy with head electrical acupuncture on proliferation of neural stem cells in substantia nigra of rat model of Parkinson. World J Acu-Mox. 2008;18:23–30.Google Scholar
  50. Jeon S, Kim YJ, Kim ST, et al. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics. 2008;8(22):4822–32.View ArticlePubMedGoogle Scholar
  51. Xie XX, Kou ST, Pu ZH, et al. Effects of scalp catgut embedding on SOD, NO, MDA in the rat with Parkinson's disease. Zhongguo Zhen Jiu. 2007;27(10):753–6.PubMedGoogle Scholar
  52. Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, Lim S. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res. 2007;1131(1):211–9.View ArticlePubMedGoogle Scholar
  53. Hwang JY, Choi IH, Park JH, et al. Acupuncture inhibits microglial activation in the rat model of Parkinson's disease. Korean J Meridian Acupoint. 2007;24(1):131–44.Google Scholar
  54. Luo EL, Zhao FZ, Li GZ, et al. Effects of acupuncture on NOS of the medial part of the globus pallidus in rat model of Parkinson's disease. J Clinic Acupunct Mox. 2007;23(1):54–5.Google Scholar
  55. Wang Q, Tang CZ, Chen XH, et al. Effects of acupuncture on dopaminergic neurons in rats with Parkinson Disease. Chin J Basic Med Tradit Chin Med. 2007;13(8):621–2.Google Scholar
  56. Jin Z, Liu TT, Zhou BX. Changes of the anti-oxidation capability of rat model of Parkinson disease after acupuncture at subthalamus. Chin J Clinic Rehabil. 2006a;10(23):188–90.Google Scholar
  57. Jin Z, Liu TT, Jiang XC, et al. Effects of electroacupuncture at subthalamus on dopamine homovanillic acid and dihydroxy-phenyl acetic acid of rats with Parkinson disease. Chin J Clinic Rehabil. 2006b;10:128–9.Google Scholar
  58. Ma J, Wang YC, Gan SY. Effects of electroacupuncture on behaviors and dopaminergic neurons in the rat of Parkinson's disease. Chin Acupunct Mox. 2006;26(9):655–7.Google Scholar
  59. Tang Y, Yu S, Chen J. Effect of Electroacupuncture on the Expression of BDNF and BDNF mRNA in Parkinson's Disease Mice. Acupunct Res. 2006;31(1):38–42.Google Scholar
  60. Wang YC, Ma J, Wang H. Changes of content of glutamic acid in striatum of rats with Parkinson disease after electroacupuncture stimulation at acupoints. Chin J Clinic Rehabil. 2006;10:183–5.Google Scholar
  61. Kim ST, Park HJ, Chae YB, et al. Acupuncture at Liver Meridian Protects the Dopaminergic Neuronal Damage in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s Disease Mouse Model. Korean J Acupunct. 2006;23(4):169–76.Google Scholar
  62. Kim YK, Lim HH, Song YK, et al. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neurosci Lett. 2005;384(1-2):133–8.View ArticlePubMedGoogle Scholar
  63. Ma J, Zhu SX. Effect of electroacupuncture on anti-oxidase in mesencephalic substantia nigra in rats with Parkinson disease. Chin J Clin Rehabil. 2005;9:120–1.Google Scholar
  64. Wang YD, Ma J, Wang H. Experimental study of the protective effect on dopaminergic neurons in substance nigra of the Parkinsonian rats by the acupuncture therapy of 'Shuanggu Yitong'. J Hubei College TCM. 2005;7(3):25–6.Google Scholar
  65. Park HJ, Lim S, Joo WS, et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp Neurol. 2003;180(1):92–7.View ArticleGoogle Scholar
  66. Liang XB, Liu XY, Li FQ, et al. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res Mol Brain Res. 2002;108:51–9.View ArticlePubMedGoogle Scholar
  67. Lin Y, Lin X. Comparative study of D2 receptors and dopamine content in striatum before and after electro-acupuncture treatment in rats. J Chin Med. 2000;113(5):408–11.Google Scholar
  68. He C, Wang L, Dong H, et al. Effects of Acupuncture - Moxibustion on the Contents of Monoamine Transmitters in the Striatum of Rats in Parkinson's Disease. Acupunct res. 1998;1:44–8.Google Scholar
  69. Zhu W, Xi G, Ju J. Effect of acupuncture and Chinese medicine treatment on brain dopamine level of MPTP-lesioned C57BL mice. Acupunct Res. 1996;4:46–9.Google Scholar
  70. Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2011;35(3):565–72.View ArticlePubMedGoogle Scholar
  71. Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol. 1998;46(5):505–11.View ArticlePubMedPubMed CentralGoogle Scholar
  72. Smith KM, Dahodwala N. Sex differences in Parkinson's disease and other movement disorders. Exp Neurol. 2014;259:44–56.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement